Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEFA-PRP for Androgenetic Alopecia
NCT05348343Phase 2Completed
- Sponsor
- Santiste Medical
- Start
- May 2022
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
Phase 2, randomised trial in androgenetic alopecia (AGA), sponsored by Santiste Medical. Primary endpoints: Change in hair density and hair regrowth at Month 8 and Measurement of hair regrowth at Month 8. Started May 2022; status: completed.
02
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT05348343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05348343.